FinZonalExplore Data →
← CompaniesCOMPANY FINANCIAL PROFILE

REGENERON PHARMACEUTICALS, INC.

REGN · CIK 0000872589 · Pharmaceutical Preparations

Last SEC sync: Nov 8, 2026 03:50 UTC

About REGENERON PHARMACEUTICALS, INC.

These statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any such statements.

Business information sourced from SEC annual filing filed Feb 4, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.

Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.

Financial highlights

Latest qualifying annual SEC observations · USD
Revenue$14.34BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Net Income$4.50BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Operating Income$3.58BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Total Assets$40.56BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Total Liabilities$9.30BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Cash and Cash Equivalents$3.12BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Operating Cash Flow$4.98BPeriod Dec. 31, 2025 · 10-K · Filed Feb. 4, 2026
Revenue growth · latest comparable annual periods1.0%
Net profit margin · matching fiscal period31.4%

Historical financial performance

USD billions · Annual SEC observations · Choose a metric

Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.

Annual financial history

USD · Exact fiscal period ends
Period endedRevenueNet incomeOperating incomeAssetsLiabilitiesCashOperating cash flowNet margin
Dec. 31, 2025$14.34B$4.50B$3.58B$40.56B$9.30B$3.12B$4.98B31.4%
Dec. 31, 2024$14.20B$4.41B$3.99B$37.76B$8.41B$2.49B$4.42B31.1%
Dec. 31, 2023$13.12B$3.95B$4.05B$33.08B$7.11B$2.73B$4.59B30.1%
Dec. 31, 2022$12.17B$4.34B$4.74B$29.21B$6.55B$3.11B$5.01B35.6%
Dec. 31, 2021$16.07B$8.08B$8.95B$25.43B$6.67B$2.89B$7.08B50.2%
Dec. 31, 2020$8.50B$3.51B$3.58B$17.16B$6.14B$2.19B$2.62B41.3%
Dec. 31, 2019$6.56B$2.12B$2.21B$14.81B$3.72B$1.62B$2.43B32.3%
Dec. 31, 2018$5.15B$2.44B$2.53B$11.73B$2.98B$1.47B$2.20B47.5%

A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.

Company information

Registered name
REGENERON PHARMACEUTICALS, INC.
Ticker symbol
REGN
CIK
0000872589
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC SIC code
2834
Fiscal year end (MMDD)
1231
Last SEC synchronization
Nov 8, 2026 03:50 UTC

Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Official website, business descriptions and executive details require separate verification.

Latest SEC filings

Browse filings →
FormFiledReport periodOfficial source
10-QOct. 30, 2026Sept. 30, 2026View SEC filing ↗
10-QJuly 30, 2026June 30, 2026View SEC filing ↗
10-QApril 29, 2026March 31, 2026View SEC filing ↗
10-QOct. 28, 2025Sept. 30, 2025View SEC filing ↗
10-QAug. 1, 2025June 30, 2025View SEC filing ↗
10-QApril 29, 2025March 31, 2025View SEC filing ↗
10-QOct. 31, 2024Sept. 30, 2024View SEC filing ↗
10-QAug. 1, 2024June 30, 2024View SEC filing ↗
10-QMay 2, 2024March 31, 2024View SEC filing ↗
10-QNov. 2, 2023Sept. 30, 2023View SEC filing ↗
10-QAug. 3, 2023June 30, 2023View SEC filing ↗
10-QMay 4, 2023March 31, 2023View SEC filing ↗
10-QNov. 3, 2022Sept. 30, 2022View SEC filing ↗
10-QAug. 3, 2022June 30, 2022View SEC filing ↗
10-QMay 4, 2022March 31, 2022View SEC filing ↗
10-QNov. 4, 2021Sept. 30, 2021View SEC filing ↗
10-QAug. 5, 2021June 30, 2021View SEC filing ↗
10-QMay 6, 2021March 31, 2021View SEC filing ↗
10-QNov. 5, 2020Sept. 30, 2020View SEC filing ↗
10-QAug. 5, 2020June 30, 2020View SEC filing ↗

Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.